IMI and IHI projects offer a secure, neutral platform for sharing public and private datasets, making them an ideal testing ground for the EHDS

IHI publishes the draft topics ahead of the call launch to give applicants extra time to start networking and preparing a proposal.

The summit explored the challenges and opportunities in regulatory science that could be best addressed by a cross-sectoral, public-private partnership like IHI

The results of a new study, published in Nature Medicine, could make life easier for people taking part in clinical trials by reducing visits to a clinic for in-person assessments.

The Innovative Medicines Initiative’s AMR Accelerator is a proven model for the development of new antimicrobial drugs, experts say.

The VAC2VAC project provided vital evidence to demonstrate that non-animal alternatives can reliably detect certain contaminants in medicines administered by injection

Health research collaborations mean sharing data – we can deliver faster if we identify and remove obstacles early, write IHI's Niklas Blomberg and EFPIA's Magda Chlebus.

Setting up a non-profit association is one way to ensure the sustainability of EU-funded project results. Two Innovative Medicines Initiative projects share their experiences as they navigate this process.

A new clinical trial testing the best administration route for an experimental arthritis treatment is using outcome measures established by IMI project RT-Cure to evaluate its performance.

A nasal vaccine against pertussis that was tested using a model and cell bank created by IMI project PERISCOPE is entering the final phases of clinical trials.